← Evidence map

ReviewExperimental dermatology2026

CD24 in Melanoma: Biomarker, Innate Immune Checkpoint and Emerging Therapeutic Target.

Claudia Lasalle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 42126185